• Ostial LAD disease: MIDCAB
• Ostial LAD disease: PCI
• Stentless PCI: The Pros
• Stentless PCI: The Cons

• The new pulmonary embolism response team (PERT), does everyone need to implement it?
• Point of care US (POCUS) in emergency cardiac care - should it be standard of care?
• Endocarditis - is transthoracic echocardiography enough, or do we all have to do multimodality assessment?
• Lp(a) - A new therapeutic target - hope or hype?

Topics coming soon

• Right and Left Heart Catheterisation for the Diagnosis and Follow-Up of the Pulmonary Arterial Hypertension Patient: Is It Necessary and How Do We Interpret the Results?
• International Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension: An ASEAN Perspective
• Approach to Pulmonary Arterial Hypertension with Comorbidities
• Novel Therapeutics in Pulmonary Arterial Hypertension: New Drugs and Pulmonary Artery Denervation

• Hypertensive Emergencies: Anything New?
• Cardiac Surgery in Acute Coronary Syndrome - Is It Still Necessary?
• VT Storm: How to Treat the Patient
• Cardiac Tamponade: How to Diagnose and What to Do in Borderline Cases?

• PCI in Patients on Dialysis: Outcomes
• Contrast-Induced Nephropathy: Myth or Reality?
• Ultra-Low-Contrast PCI: Past, Present, and Future
• Live-in-a-Box: Low-Contrast Case
• Real Time IVUS

• Tetralogy of Fallot: Current Outcomes and the Brunei Experience
• Cardiac issues in the paediatric intensive care unit
• The Role of the Transition Clinic in the Management of Congenital Heart Disease: Easing the Journey to Adult Care
• Highlights from the 2025 ACC/AHA Guideline for the Management of ACHD

• Controversies Related to Therapeutic Hypothermia Post-Cardiac Arrest: The Case For and Against
• Special Circumstances in Resuscitation: Beyond the Basics
• See the Cause, Save the Patient: Bedside Echo in Cardiac Arrest
• 2025 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care (ECC) Science With Treatment Recommendations: What's New and Why Has It Changed?

• Case presentation
• PCI in Patients with Low Ejection Fraction: Pros vs. Cons
• Impella: A Debate on the Current Evidence
• Left Main PCI Strategy
• DCB: Current State of the Art
• How did we do it? – Film

• Risk Scoring for Atherosclerotic Cardiovascular Disease: A Review of the WHO, European, and American Risk Scores
• The Development and Rationale of SCORE2 Asia Pacific: Should We Routinely Be Using It?
• Risk Prediction in Patients with Established ASCVD, Type 2 Diabetes, and Heart Failure
• Lifetime and Residual Cardiovascular Disease Risk: What Models Exist for Prediction, and How Are They Derived?

• The Role of CT in the Assessment of Coronary Artery Disease: Beyond Coronary Artery Calcium and CT Coronary Angiography
• Photon-Counting CT: The New Gold Standard?
• How to Diagnose Anomalous Coronary Artery Disease: Classification Using CT and Risk Stratification
• Beyond Troponin and Echo: The Use of Cardiac CT in the Early Assessment of Chest Pain in the Emergency Department

• ERAS in Cardiac Surgery: Does It Truly Reduce Morbidity or Just Length of Stay?
• PCI vs. CABG for Left Main and Multivessel Coronary Artery Disease: Early Outcomes vs. Long-Term Survival
• Outcomes of SAVR vs. TAVI in Low-Risk Younger Patients with Severe Aortic Stenosis
• Management of Acute Aortic Syndromes: Surgery vs TEVAR

• Updated Clinical Models to Estimate Obstructive CAD
• Management of Angina in Patients with ANOCA/MINOCA
• Management of High-Risk Patients Requiring Long-Term Anticoagulation After Stenting
• Post-PCI Angina

• The Role of Multimodality Cardiovascular Imaging in the Evaluation of Young Adult Competitive Athletes
• Multimodality Imaging for the Evaluation of Patients with Heart Failure and Reduced Ejection Fraction
• The role of nuclear imaging in cardiology - when to use it in the modern era
• Multimodality Imaging in Hypertrophic Cardiomyopathy: How to Use It to Guide Novel Therapeutics

• Cardio-Oncology: What the General Cardiologist Needs to Know
• Cardiac-Oculomics: Retinal Imaging as a Window into Cardiovascular Health
• Cardiac Amyloidosis: Current Therapeutic Approach
• Iron Overload Cardiomyopathy in Thalassaemia and Beyond

• Debate: PPCI for All – Agree
• Debate: PPCI for All- Disagree
• From Aspiration to Reality: Malaysia
• From Aspiration to Reality: Indonesia

• PCI of Non-Culprit Vessels: Physiology- vs. Imaging-Guided
• Treatment Options in Real-Life Cases
• Final Discussion and Conclusions

• Antiplatelets: Ticagrelor—In or Out?
• Lipid Lowering: Are We Ready for PCSK9 Inhibitors in the Context of Acute Coronary Syndromes?
• Novel Targets in Acute Coronary Syndromes

• HFpEF: Phenotyping Beyond Ejection Fraction
• Disease-Modifying Therapies Across the Cardio-Renal-Metabolic Spectrum
• Evolving Roles for Device and Monitoring Technologies
• GDMT 2026: Are We Treating the Four Pillars Early Enough in ASEAN?

• Rheumatic Revelations: Navigating Rheumatic Mitral Stenosis in Resource-Limited Settings
• Peripartum Problems: Visualizing Valve Disease and Cardiomyopathies in Pregnancy
• Congenital Conundrums: Unravelling Bicuspid Aortic Valve with Aortic Stenosis and Concomitant Congenital Lesions
• Innovation Spotlight: Engineering AI-powered strategies in echocardiography across the ASEAN region

Topics coming soon

• Door to Lactate
• PCI first or support first
• Supporting the RV in massive PE

• Asymptomatic PVCs: What Do I Do?
• Evaluation of the Young Person with Bradycardia: Do I Need to Pace Them?
• Narrow Complex Tachycardias: Clues to Diagnosis from the 12-Lead ECG
• Shared Decision Making in the Spotlight - Can My Patient with Arrhythmias Play Sport or Compete Professionally?

• Asia-Pacific Cardiovascular Research Network (ASPIRE) Network: A New Collaboration
• How to Treat the Patient with High Triglycerides
• Factor XI Inhibitors and Their Potential Antithrombotic Role in Common Cardiovascular Conditions
• Familial Hyperlipidaemia: How to Diagnose and Treat

• Transcatheter Intervention in Valvular Heart Disease & Heart Failure: When & Who?
• Broken Pumps and Added Weight: Obesity's Role in Heart Dysfunction
• Precious Ejection, Fragile Filtration: The CKD-HFpEF Nexus
• Revascularizing the Hibernating Heart: Updated Evidence on CABG vs. PCI

• Lifetime Management of Aortic Stenosis
• What to Do When TAVI/SAVR Starts to Fail?
• TAVI for Asymptomatic Severe and Moderate Aortic Stenosis- The Next Frontier?
• Intracardiac Echo in Structural Heart Disease Intervention

• Pulsed Field Ablation for Atrial Fibrillation and Beyond
• Conduction System Pacing- A Cure for All Evils?
• Leadless Pacemakers- Will Devices Last a Lifetime?
• Early Rhythm Control for Atrial Fibrillation - EAST-AFNET4 and beyond

• A Comparison of the Latest European, American, and ASEAN Guidelines for Hypertension
• Endocrine Causes of Secondary Hypertension- What the General Cardiologist Needs to Know
• Renal Denervation in 2026- Where Are We Now?
• Challenging Scenarios in Hypertension Management- What Do We Do for End-Stage Renal Disease, Elderly Patients with Postural Hypotension, and Neurocardiogenic Syncope?

• Imaging Assessment for Percutaneous Treatment of Mitral Valve Disease
• Current Role of Transcatheter Edge-to-Edge Repair in Mitral Regurgitation
• Assessment of the Tricuspid Valve for Transcatheter Therapies, with a Focus on TTE and TOE
• Does Transcatheter Treatment of Tricuspid Regurgitation Have a Role? TEER for TR and Percutaneous Valve Therapies

• AF Detection & Screening: How Far Should We Go After an Embolic Stroke?
• AF Stroke Prevention: LAAO vs DOAC – New Guidelines and Real World Data
• Patent Foramen Ovale and Stroke: Decoding the Hidden Link in Cryptogenic Ischaemic Stroke
• Infective Endocarditis & Stroke: Practical Imaging Pathways and Safer Surgical Timing

• The Rising Burden of Cardiovascular Disease: The Expanding and Evolving Roles of Cardiac Nurses
• My Cardiac Nursing Journey: Professional Growth and Competency Development (MOH)
• Nurse-led Genetic Cascade Screening: Preventing Heart Failure in Families with Inherited Cardiomyopathy (MOH)
• Advancing Heart Failure Care: Nurse-led Education and Digital Health Integration (IJN)
• Advancing Anticoagulation Care: Nurse-led Warfarin Management Using POCT and AI Integration (MOH)

• The Prevalence of Cardiovascular Risk Factors Across ASEAN- A Call to Action
• Population-Level Strategies to Reduce the Burden of Cardiovascular Disease – Do Any of Them Work?
• Obesity, GLP-1 Agonists, and Beyond- The Role of Cardiologists
• Sports Cardiology – What a General Cardiologist Needs to Know: Balancing Performance and Risk

• Hypertrophic Cardiomyopathy- How Do We Risk Stratify for Sudden Cardiac Death?
• Brugada Syndrome- Do We Need to Consider It a High-Risk Condition for Sudden Cardiac Death in ASEAN?
• Arrhythmogenic Cardiomyopathy and the Risk of Sudden Death- Should We Restrict Exercise?
• How do we treat patients at high risk of sudden cardiac death with genetic cardiomyopathies - the role of medication and novel defibrillator technologies

• Managing Vasovagal Events in Cath Lab (GJPMC)-Nursing Perspective
• Nursing Perspective - Management of Cardiac Arrest in the Cath Lab (GJPMC)
• Operational Responsibilities of CVTs in the Catheterization Laboratory
• Understanding ECGs & EGMs in IPG device
• Code Blue Simulation Program (GJPMC)

• AI in Myocardial Tissue Characterization using CMR
• AI-Powered Coronary Artery Disease Assessment: Using CCTA-Based Tools for Plaque Analysis, Flow Reserve (FFR-CT), and FAI to Detect High-Risk Patients
• AI Applications in Aortic CT
• AI in Heart Failure (Echocardiography): Automated Reporting and Detection of Diastolic Dysfunction

• Gender-Specific Cardiovascular Phenotypes: The Role of Multimodality Cardiac Imaging in Women with Ischemic Heart Disease
• Management of pregnancy in uncorrected cyanotic heart disease
• Young, Female, and at Risk: The Growing Burden of Heart Disease in Young Women
• Her Valve, Different Story: Aortic Valve Disease in Women

• The Clinician as the Innovator: Why Cardiologists Must Lead AI Development- From Bedside Frustrations to Building Real- World Solutions That Work
• Prompt Engineering for Cardiologists: A Practical "How-To" on Getting High-Quality, Safe, and Clinically Useful Responses from Medical AI- Best Models, Best Practices, and Live Demonstrations
• "Wearables & Remote Monitoring: Integrating Smartwatch ECGs, PPG- Data, and Consumer Health Devices into ASEAN Clinical Workflows for AF Detection, Heart Failure Monitoring, and Beyond"
• The Ethics of AI in Cardiology: Navigating Accountability, Data Privacy, Algorithmic Bias, and the Liability of AI- Assisted Diagnosis in Diverse ASEAN Healthcare Systems

• The Role of AI in Medical Publishing

• Scene-setting talk: Cardiac Physiology in the UK
• Scene-setting talk: Cardiovascular Technology in Malaysia